These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6782926

  • 1. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.
    Neuwelt EA, Diehl JT, Vu LH, Hill SA, Michael AJ, Frenkel EP.
    Ann Intern Med; 1981 Apr; 94(4 pt 1):449-54. PubMed ID: 6782926
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
    Neuwelt EA, Rapoport SI.
    Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941
    [Abstract] [Full Text] [Related]

  • 8. CT monitoring of chemotherapeutic agent delivery after osmotic blood brain barrier disruption.
    Neuwelt EA.
    Clin Neurosurg; 1981 Feb; 28():520-31. PubMed ID: 6895614
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
    Neuwelt EA, Hill SA, Frenkel EP, Diehl JT, Maravilla KR, Vu LH, Clark WK, Rapoport SI, Barnett PA, Lewis SE, Ehle AL, Beyer CW.
    Cancer Treat Rep; 1981 Feb; 65 Suppl 2():39-43. PubMed ID: 6809316
    [Abstract] [Full Text] [Related]

  • 11. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
    Siegal T, Rubinstein R, Bokstein F, Schwartz A, Lossos A, Shalom E, Chisin R, Gomori JM.
    J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening.
    Neuwelt EA, Balaban E, Diehl J, Hill S, Frenkel E.
    Neurosurgery; 1983 Jun; 12(6):662-71. PubMed ID: 6410302
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption].
    Yamada K, Takahama H, Nakai O, Takanashi T, Hosoya T.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2692-6. PubMed ID: 2506817
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.